Synopsis

Source of validity: Scientific
Rating (out of 5): 3

Fava beans (Vicia faba), also known as broad beans, have been investigated as a possible supportive treatment for Parkinson's Disease due to their natural content of L-dopa, the same precursor to dopamine used in standard pharmaceutical therapy (levodopa). Historically, some traditional medicine systems have used fava beans for neurological symptoms, but the primary justification for their use in Parkinson's Disease is scientific: several studies have measured the L-dopa content of fava beans and examined their effect on Parkinsonian symptoms.

Small clinical studies and case reports suggest that consumption of fava beans can increase plasma L-dopa levels and may temporarily improve symptoms such as rigidity and bradykinesia in people with Parkinson's. For example, a 1995 study found significant improvement in motor function after ingestion of fava beans, with effects comparable to pharmaceutical levodopa/carbidopa. However, the amount of L-dopa in fava beans varies widely, and the actual dose is difficult to control, raising concerns about safety and efficacy. Moreover, the beans lack carbidopa, the standard adjunct that prevents peripheral metabolism of L-dopa, which may increase the risk of side effects like nausea or hypotension.

Overall, while there is scientific evidence that fava beans contain L-dopa and can affect Parkinson's symptoms, the evidence base is limited (hence a rating of 3), and fava beans are not a substitute for well-controlled pharmaceutical preparations. Individuals with Parkinson's should consult their neurologist before using fava beans therapeutically.

More about fava bean
More about Parkinson's Disease

Other ingredients used for Parkinson's Disease

Other health conditions supported by fava bean

Products containing fava bean

Designs For Health Performance/ProFormance Peptides